Default company panoramic image
Final

Feldan

Feldan will be the leader in ancillary product for the cell therapy.

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location Quebec, QC, Canada
  • Currency CAD
  • Founded May 2007
  • Employees 18
  • Website feldan.com

Company Summary

Feldan’s mission is to be a premium provider of ancillary materials such as clinical grade cytokines and transcription factors critical to the development and application of cell therapy.
Feldan is also developing a breakthrough technology based on Shuttle Proteins for the translocation of transcription factors and genome editing techniques.

Team

  • 494f6842 00e7 4169 bd20 f2ec18df1b17
    Chief Executive Officer

    CEO & co-founder of Feldan - 2007
    Ph.D. Chemical Engineering, University Laval - 2009
    B. eng. Chemical Engineering, University Laval - 2004

  • Default avatar
    Benoit Cyr
    Executive Chariman

    CEO and founder of Biogenie a biotechnological environment company sold in 2007 with sales of 75M$ and 300 employees worldwide.